Cycle Pharmaceuticals

About Cycle Pharmaceuticals

Cycle Pharmaceuticals is a UK-based pharmaceutical company dedicated to improving patient outcomes through innovative therapies. Established with a vision to address unmet medical needs, we focus on developing and commercialising high-quality medicines for rare diseases and niche indications.

Our core activities encompass the entire lifecycle of pharmaceutical development, from research and development to regulatory approval and market access. We pride ourselves on our commitment to quality, ensuring that all our products meet the highest standards of safety and efficacy.

At Cycle Pharmaceuticals, we believe in collaboration and partnership. We work closely with healthcare professionals, patients, and other stakeholders to understand their needs and tailor our solutions accordingly. Our team comprises experienced professionals with diverse backgrounds in pharmaceuticals, biotechnology, and healthcare.

We are also committed to sustainability and ethical practices, striving to minimise our environmental impact while delivering value to our customers and shareholders. Our pipeline includes several promising candidates that are currently in various stages of clinical trials.

As we look to the future, Cycle Pharmaceuticals aims to expand its portfolio and reach more patients globally. We are driven by our mission to transform lives through innovative healthcare solutions.

• Core Focus: Rare diseases and niche indications
• Commitment: Quality and safety in all products
• Collaboration: Working with healthcare professionals and stakeholders
• Sustainability: Ethical practices and environmental responsibility